Welcome to our dedicated page for Quantum Cyber N.V. SEC filings (Ticker: QUCY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Quantum Cyber N.V.'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Quantum Cyber N.V.'s regulatory disclosures and financial reporting.
Quantum Cyber N.V. is soliciting proxies for its Annual General Meeting to be held June 29, 2026 at 14.00 hours Central European Time in Amsterdam. Shareholders of record as of June 1, 2026 may vote in person; proxy materials were first made available on or about June 8, 2026.
The Board asks shareholders to vote "FOR" eleven proposals covering auditor ratification, adoption of the statutory annual accounts for the year ended December 31, 2025, discharge of directors, authorizations to issue and acquire shares and preferred shares (extensions to June 28, 2031 and December 28, 2027 where specified), amendments to the articles to add cyber/defense objects, the appointment of Peter O’Rourke to the Board, and an amended remuneration policy. The Board recommends approval of all proposals.
Quantum Cyber N.V. reported an intended sale of 200,000 shares by Guido Baechler via a Form 144 filing.
The filing also lists a 240,000-share stock award dated 04/22/2026 and a line showing 240,000 common shares with an associated value of $904,800.00 dated 05/22/2026.
Quantum Cyber N.V. reported an intended sale of 200,000 shares by Guido Baechler via a Form 144 filing.
The filing also lists a 240,000-share stock award dated 04/22/2026 and a line showing 240,000 common shares with an associated value of $904,800.00 dated 05/22/2026.
Quantum Cyber N.V. director Peter O'Rourke has filed an initial Form 3 reporting his beneficial ownership in the company’s ordinary shares. The filing shows he beneficially owns no ordinary shares as of May 13, 2026, as confirmed by the footnote stating that no ordinary shares are beneficially owned.
Quantum Cyber N.V. director Peter O'Rourke has filed an initial Form 3 reporting his beneficial ownership in the company’s ordinary shares. The filing shows he beneficially owns no ordinary shares as of May 13, 2026, as confirmed by the footnote stating that no ordinary shares are beneficially owned.
NATAN DAVID reported acquisition or exercise transactions in this Form 4 filing.
Quantum Cyber N.V. director Natan David received a grant of ordinary shares as compensation. On May 8, 2026, he was awarded 137,141 ordinary shares at a stated price of $0.00 per share, bringing his directly held stake to 137,141 shares after the transaction.
NATAN DAVID reported acquisition or exercise transactions in this Form 4 filing.
Quantum Cyber N.V. director Natan David received a grant of ordinary shares as compensation. On May 8, 2026, he was awarded 137,141 ordinary shares at a stated price of $0.00 per share, bringing his directly held stake to 137,141 shares after the transaction.
Quantum Cyber N.V. entered into a significant Intellectual Property License Agreement with BP United Inc., gaining an exclusive, perpetual, fully paid-up worldwide license to commercialize technology across multiple applications, including drones and cyber technology. As consideration, subject to conditions precedent, the company agreed to pay $5,000,000 in cash and issue 20,000,000 restricted shares of common stock with a six-month lock-up and a five percent average weighted volume restriction.
The company may terminate the license and a related supply agreement within ninety days if due diligence and other conditions are not satisfied, and it can terminate the license at any time on notice. Quantum Cyber also entered into an Advisory Agreement with Alexander Gurevich, issuing 5,000,000 restricted ordinary shares at $0.40 per share for a 12‑month advisory term, and appointed Peter O’Rourke as a new director.
Quantum Cyber N.V. entered into a significant Intellectual Property License Agreement with BP United Inc., gaining an exclusive, perpetual, fully paid-up worldwide license to commercialize technology across multiple applications, including drones and cyber technology. As consideration, subject to conditions precedent, the company agreed to pay $5,000,000 in cash and issue 20,000,000 restricted shares of common stock with a six-month lock-up and a five percent average weighted volume restriction.
The company may terminate the license and a related supply agreement within ninety days if due diligence and other conditions are not satisfied, and it can terminate the license at any time on notice. Quantum Cyber also entered into an Advisory Agreement with Alexander Gurevich, issuing 5,000,000 restricted ordinary shares at $0.40 per share for a 12‑month advisory term, and appointed Peter O’Rourke as a new director.
Quantum Cyber N.V. entered into a significant Intellectual Property License Agreement with BP United Inc., gaining an exclusive, perpetual, fully paid-up worldwide license to commercialize technology across multiple applications, including drones and cyber technology. As consideration, subject to conditions precedent, the company agreed to pay $5,000,000 in cash and issue 20,000,000 restricted shares of common stock with a six-month lock-up and a five percent average weighted volume restriction.
The company may terminate the license and a related supply agreement within ninety days if due diligence and other conditions are not satisfied, and it can terminate the license at any time on notice. Quantum Cyber also entered into an Advisory Agreement with Alexander Gurevich, issuing 5,000,000 restricted ordinary shares at $0.40 per share for a 12‑month advisory term, and appointed Peter O’Rourke as a new director.
Quantum Cyber N.V. entered into a significant Intellectual Property License Agreement with BP United Inc., gaining an exclusive, perpetual, fully paid-up worldwide license to commercialize technology across multiple applications, including drones and cyber technology. As consideration, subject to conditions precedent, the company agreed to pay $5,000,000 in cash and issue 20,000,000 restricted shares of common stock with a six-month lock-up and a five percent average weighted volume restriction.
The company may terminate the license and a related supply agreement within ninety days if due diligence and other conditions are not satisfied, and it can terminate the license at any time on notice. Quantum Cyber also entered into an Advisory Agreement with Alexander Gurevich, issuing 5,000,000 restricted ordinary shares at $0.40 per share for a 12‑month advisory term, and appointed Peter O’Rourke as a new director.
Quantum Cyber N.V. reported a net loss of $5.1 million for the quarter ended March 31, 2026, similar to the prior-year loss of $5.0 million. Continuing operations generated no revenue, while discontinued colorectal cancer activities produced $170,105 in revenue before being classified as held for sale.
Total operating expenses from continuing operations were $2.46 million, driven mainly by $2.12 million in general and administrative costs, including significant share-based compensation. The company ended the quarter with cash of $4.75 million and shareholders’ equity of $4.59 million, helped by $6.0 million of preferred share funding and $2.1 million from ordinary share issuances.
Management states that recurring losses, a large accumulated deficit of about $110 million, and limited revenue create “substantial doubt” about the ability to continue as a going concern. Strategically, Quantum Cyber has exited colorectal cancer screening, is focusing on its pancreatic cancer program, and is expanding into post‑quantum cybersecurity, including a subsequent license deal requiring up to $5.0 million in cash and 20 million shares, plus 5 million shares for an advisor, subject to conditions.
Quantum Cyber N.V. reported a net loss of $5.1 million for the quarter ended March 31, 2026, similar to the prior-year loss of $5.0 million. Continuing operations generated no revenue, while discontinued colorectal cancer activities produced $170,105 in revenue before being classified as held for sale.
Total operating expenses from continuing operations were $2.46 million, driven mainly by $2.12 million in general and administrative costs, including significant share-based compensation. The company ended the quarter with cash of $4.75 million and shareholders’ equity of $4.59 million, helped by $6.0 million of preferred share funding and $2.1 million from ordinary share issuances.
Management states that recurring losses, a large accumulated deficit of about $110 million, and limited revenue create “substantial doubt” about the ability to continue as a going concern. Strategically, Quantum Cyber has exited colorectal cancer screening, is focusing on its pancreatic cancer program, and is expanding into post‑quantum cybersecurity, including a subsequent license deal requiring up to $5.0 million in cash and 20 million shares, plus 5 million shares for an advisor, subject to conditions.
Quantum Cyber N.V. reported a net loss of $5.1 million for the quarter ended March 31, 2026, similar to the prior-year loss of $5.0 million. Continuing operations generated no revenue, while discontinued colorectal cancer activities produced $170,105 in revenue before being classified as held for sale.
Total operating expenses from continuing operations were $2.46 million, driven mainly by $2.12 million in general and administrative costs, including significant share-based compensation. The company ended the quarter with cash of $4.75 million and shareholders’ equity of $4.59 million, helped by $6.0 million of preferred share funding and $2.1 million from ordinary share issuances.
Management states that recurring losses, a large accumulated deficit of about $110 million, and limited revenue create “substantial doubt” about the ability to continue as a going concern. Strategically, Quantum Cyber has exited colorectal cancer screening, is focusing on its pancreatic cancer program, and is expanding into post‑quantum cybersecurity, including a subsequent license deal requiring up to $5.0 million in cash and 20 million shares, plus 5 million shares for an advisor, subject to conditions.
Quantum Cyber N.V. reported a net loss of $5.1 million for the quarter ended March 31, 2026, similar to the prior-year loss of $5.0 million. Continuing operations generated no revenue, while discontinued colorectal cancer activities produced $170,105 in revenue before being classified as held for sale.
Total operating expenses from continuing operations were $2.46 million, driven mainly by $2.12 million in general and administrative costs, including significant share-based compensation. The company ended the quarter with cash of $4.75 million and shareholders’ equity of $4.59 million, helped by $6.0 million of preferred share funding and $2.1 million from ordinary share issuances.
Management states that recurring losses, a large accumulated deficit of about $110 million, and limited revenue create “substantial doubt” about the ability to continue as a going concern. Strategically, Quantum Cyber has exited colorectal cancer screening, is focusing on its pancreatic cancer program, and is expanding into post‑quantum cybersecurity, including a subsequent license deal requiring up to $5.0 million in cash and 20 million shares, plus 5 million shares for an advisor, subject to conditions.
Quantum Cyber N.V. amended its Equity Distribution Agreement with Maxim Group LLC to raise the capacity of its at-the-market share offering program from $10,000,000 to up to $100,000,000 of ordinary shares.
The company also entered into a Consulting Agreement with Chief Financial Officer William Caragol, effective April 22, 2026. He will provide chief financial officer-level financial and accounting services for a monthly retainer of $20,000, with potential stock or option grants under the 2025 Omnibus Stock Plan at the board’s discretion. The consulting term runs through August 31, 2026 and may continue month to month, and either party can terminate with 30 days’ written notice.
Quantum Cyber N.V. amended its Equity Distribution Agreement with Maxim Group LLC to raise the capacity of its at-the-market share offering program from $10,000,000 to up to $100,000,000 of ordinary shares.
The company also entered into a Consulting Agreement with Chief Financial Officer William Caragol, effective April 22, 2026. He will provide chief financial officer-level financial and accounting services for a monthly retainer of $20,000, with potential stock or option grants under the 2025 Omnibus Stock Plan at the board’s discretion. The consulting term runs through August 31, 2026 and may continue month to month, and either party can terminate with 30 days’ written notice.
Quantum Cyber N.V. director Ben-Tzvi Avraham filed an initial Form 3 reporting beneficial ownership of the company’s ordinary shares. The filing shows he holds 2,000 Ordinary Shares directly after the reported date, providing a baseline of his equity position as an insider.
Quantum Cyber N.V. director Ben-Tzvi Avraham filed an initial Form 3 reporting beneficial ownership of the company’s ordinary shares. The filing shows he holds 2,000 Ordinary Shares directly after the reported date, providing a baseline of his equity position as an insider.
Quantum Cyber N.V. filed an initial insider ownership report for director Natan David. The Form 3 shows that he currently holds no ordinary shares beneficially owned, as confirmed by the filing’s footnote. This establishes a baseline of zero reported ownership for future insider filings.
Quantum Cyber N.V. filed an initial insider ownership report for director Natan David. The Form 3 shows that he currently holds no ordinary shares beneficially owned, as confirmed by the filing’s footnote. This establishes a baseline of zero reported ownership for future insider filings.